| 1LZQ | B:104-198; B:104-198 | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH AN ETHYLENAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2 |
| 1M0B | B:104-198; B:104-198 | HIV-1 PROTEASE IN COMPLEX WITH AN ETHYLENEAMINE INHIBITOR |
| 1MRW | B:4-98; B:4-98 | STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-577 |
| 1MSM | B:4-98; B:4-98 | THE HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-764 (AN INHIBITOR) |
| 1MSN | B:4-98; B:4-98 | THE HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V) COMPLEXED WITH KNI-764 (AN INHIBITOR) |
| 1NH0 | B:4-98; B:4-98 | 1.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE |
| 1RL8 | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV-1 PROTEASE(V82A MUTANT) WITH RITONAVIR |
| 1SDT | B:104-198; B:104-198 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SDU | B:104-198; B:104-198 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SDV | B:104-198; B:104-198 | CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. |
| 1SGU | B:4-98; B:4-98 | COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE |
| 1SH9 | B:4-98; B:4-98 | COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE |
| 1SP5 | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS |
| 1U8G | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2 |
| 1UPJ | A:4-98 | HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN |
| 1XL2 | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE |
| 1XL5 | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE |
| 1Z8C | B:104-198; B:104-198 | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 |
| 1ZBG | B:104-198; B:104-198 | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 |
| 1ZJ7 | A:4-98 | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 |
| 1ZLF | B:104-198; B:104-198 | CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR |
| 1ZPK | B:104-198; B:104-198 | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 |
| 1ZTZ | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX |
| 2O4L | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, I50V) IN COMPLEX WITH TIPRANAVIR |
| 2O4N | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (TRM MUTANT) IN COMPLEX WITH TIPRANAVIR |
| 2O4P | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH TIPRANAVIR |
| 2O4S | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH LOPINAVIR |
| 2P3B | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR |
| 2PK5 | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I ) IN COMPLEX WITH KNI-10075 |
| 2PK6 | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10033 |
| 2PQZ | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE-BASED INHIBITOR |
| 2PWC | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR |
| 2PWR | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR |
| 2PYM | B:4-98; B:4-98 | HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR |
| 2PYN | B:4-98; B:4-98 | HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR |
| 2Q63 | B:4-98; B:4-98 | HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR |
| 2Q64 | B:4-98; B:4-98 | HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR |
| 2QAK | B:4-98; B:4-98 | HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR |
| 2QCI | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT D30N WITH POTENT ANTIVIRAL INHIBITOR GRL-98065 |
| 2QD7 | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT V82A WITH POTENT ANTIVIRAL INHIBITOR GRL-98065 |
| 2QHC | B:4-98; B:4-98 | THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR |
| 2QNN | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A MULTIPLE DECORATED PYRROLIDINE-BASED INHIBITOR |
| 2QNQ | B:4-98; B:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A CHLORO DECORATED PYRROLIDINE-BASED INHIBITOR |
| 2R43 | B:4-98; B:4-98 | I50V HIV-1 PROTEASE IN COMPLEX WITH AN AMINO DECORATED PYRROLIDINE-BASED INHIBITOR |
| 2UPJ | B:4-98; B:4-98 | HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER) |
| 2Z4O | B:104-198; B:104-198 | WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-98065 |
| 2ZGA | A:4-98 | HIV-1 PROTEASE IN COMPLEX WITH A DIMETHYLALLYL DECORATED PYRROLIDINE BASED INHIBITOR (HEXAGONAL SPACE GROUP) |
| 2ZYE | B:104-198; B:104-198 | STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR KNI-272 DETERMINED BY NEUTRON CRYSTALLOGRAPHY |
| 3JVW | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323 |
| 3JW2 | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR |
| 3KDB | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10006 |
| 3KDC | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10074 |
| 3KDD | B:4-98; B:4-98 | CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10265 |
| 3PWM | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT L76V WITH DARUNAVIR |
| 3PWR | B:104-198; B:104-198 | HIV-1 PROTEASE MUTANT L76V COMPLEXED WITH SAQUINAVIR |
)
)